Human Babesiosis.
暂无分享,去创建一个
[1] J. Gelfand,et al. Clofazimine for babesiosis: preclinical data support a clinical trial. , 2021, The Journal of infectious diseases.
[2] X. Xuan,et al. A combination of clofazimine‒atovaquone as a potent therapeutic regimen for the radical cure of Babesia microti infection in immunocompromised hosts. , 2021, The Journal of infectious diseases.
[3] P. Krause,et al. Recurrence of Human Babesiosis Caused by Reinfection , 2021, Emerging infectious diseases.
[4] Corrigendum to: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] Raveendhara R. Bannuru,et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA): 2020 Guideline on Diagnosis and Management of Babesiosis. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] J. Gelfand,et al. Case Report: Overwhelming Babesia Parasitemia Successfully Treated Promptly With RBC Apheresis and Triple Therapy With Clindamycin, Azithromycin, and Atovaquone , 2020, Open forum infectious diseases.
[7] M. Diuk-Wasser,et al. Vertical transmission: A vector-independent transmission pathway of Babesia microti in the natural reservoir host Peromyscus leucopus. , 2020, The Journal of infectious diseases.
[8] D. Lipsker,et al. Human babesiosis in Alsace. , 2020, Medecine et maladies infectieuses.
[9] Jianfeng Dai,et al. Babesia microti Protein BmSP44 Is a Novel Protective Antigen in a Mouse Model of Babesiosis , 2020, Frontiers in Immunology.
[10] P. Krause,et al. Management strategies for human babesiosis , 2020, Expert review of anti-infective therapy.
[11] P. Krause,et al. Repeat exchange transfusion for treatment of severe babesiosis. , 2019, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[12] J. R. Cursino-Santos,et al. Babesia divergens: A Drive to Survive , 2019, Pathogens.
[13] J. O’Horo,et al. Babesiosis: A Retrospective Review of 38 Cases in the Upper Midwest , 2019, Open forum infectious diseases.
[14] N. Dunbar,et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue , 2019, Journal of clinical apheresis.
[15] B. Herwaldt,et al. Babesiosis Surveillance - United States, 2011-2015. , 2019, Morbidity and mortality weekly report. Surveillance summaries.
[16] G. Wormser,et al. Could the Drug Tafenoquine Revolutionize Treatment of Babesia microti Infection? , 2019, The Journal of infectious diseases.
[17] G. Wormser,et al. Babesiosis as a cause of acute respiratory distress syndrome: a series of eight cases , 2018, Postgraduate medicine.
[18] L. Mermel,et al. Babesiosis-Associated Splenic Rupture: Case Series from a Hyperendemic Region. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] C. Munoz-Zanzi,et al. Human Babesiosis, Yucatán State, Mexico, 2015 , 2018, Emerging infectious diseases.
[20] N. Gupta,et al. Splenic rupture from babesiosis, an emerging concern? A systematic review of current literature. , 2018, Ticks and tick-borne diseases.
[21] B. Munoz,et al. Babesia microti and Malaria Infection in Africa: A Pilot Serosurvey in Kilosa District, Tanzania. , 2018, The American journal of tropical medicine and hygiene.
[22] P. Ramanan,et al. Splenic Rupture as the First Manifestation of Babesia Microti Infection: Report of a Case and Review of Literature , 2018, The American journal of case reports.
[23] S. Telford,et al. Zoonotic Babesia microti in the northeastern U.S.: Evidence for the expansion of a specific parasite lineage , 2017, bioRxiv.
[24] A. Schotthoefer,et al. Risk Factors for Severe Infection, Hospitalization, and Prolonged Antimicrobial Therapy in Patients with Babesiosis. , 2017, The American journal of tropical medicine and hygiene.
[25] L. Westblade,et al. Clinical and Molecular Evidence of Atovaquone and Azithromycin Resistance in Relapsed Babesia microti Infection Associated With Rituximab and Chronic Lymphocytic Leukemia , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] B. Fries,et al. Babesiosis in Long Island: review of 62 cases focusing on treatment with azithromycin and atovaquone , 2017, Annals of Clinical Microbiology and Antimicrobials.
[27] F. Marty,et al. Post‐Babesiosis Warm Autoimmune Hemolytic Anemia , 2017, The New England journal of medicine.
[28] S. Stramer,et al. Screening for Babesia microti in the U.S. Blood Supply. , 2016, The New England journal of medicine.
[29] M. Oberley,et al. Transmission of Babesia microti Parasites by Solid Organ Transplantation , 2016, Emerging infectious diseases.
[30] P. Krause,et al. Apheresis for babesiosis: Therapeutic parasite reduction or removal of harmful toxins or both? , 2016, Journal of clinical apheresis.
[31] Choukri Ben Mamoun,et al. Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone , 2016, The Journal of experimental medicine.
[32] Pardis C. Sabeti,et al. A global map of genetic diversity in Babesia microti reveals strong population structure and identifies variants associated with clinical relapse , 2016, Nature Microbiology.
[33] G. Wormser,et al. Diagnosis, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: A Review. , 2016, JAMA.
[34] Choukri Ben Mamoun,et al. Babesiosis. , 2015, Infectious disease clinics of North America.
[35] G. Wormser,et al. Neutropenia in Congenital and Adult Babesiosis. , 2015, American journal of clinical pathology.
[36] G. Wormser,et al. Comparison of a quantitative PCR assay with peripheral blood smear examination for detection and quantitation of Babesia microti infection in humans. , 2015, Diagnostic microbiology and infectious disease.
[37] R. Molestina,et al. Development of droplet digital PCR for the detection of Babesia microti and Babesia duncani. , 2015, Experimental parasitology.
[38] Durland Fish,et al. Borrelia burgdorferi Promotes the Establishment of Babesia microti in the Northeastern United States , 2014, PloS one.
[39] Xiaoping Zhou,et al. Human babesiosis, an emerging tick-borne disease in the People’s Republic of China , 2014, Parasites & Vectors.
[40] G. Foster,et al. Investigational screening for Babesia microti in a large repository of blood donor samples from nonendemic and endemic areas of the United States , 2014, Transfusion.
[41] D. Kessler,et al. Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay , 2014, Transfusion.
[42] A. Paparini,et al. Molecular confirmation of the first autochthonous case of human babesiosis in Australia using a novel primer set for the beta-tubulin gene. , 2014, Experimental parasitology.
[43] Choukri Ben Mamoun,et al. Quantitative PCR for detection of Babesia microti in Ixodes scapularis ticks and in human blood. , 2013, Vector borne and zoonotic diseases.
[44] G. Bachowski,et al. Babesia microti seroprevalence in Minnesota blood donors , 2013, Transfusion.
[45] P. Krause,et al. Transplacental Transmission of Human Babesiosis , 2012 .
[46] J. R. Cursino-Santos,et al. Babesia and red cell invasion , 2012, Current opinion in hematology.
[47] I. Bogoch,et al. Severe babesiosis in a patient treated with a tumor necrosis factor α antagonist. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[48] S. Madison‐Antenucci,et al. A New Real-Time PCR Assay for Improved Detection of the Parasite Babesia microti , 2011, Journal of Clinical Microbiology.
[49] B. Herwaldt,et al. Transfusion-Associated Babesiosis in the United States: A Description of Cases , 2011, Annals of Internal Medicine.
[50] S. Reis,et al. Spontaneous splenic rupture secondary to Babesia microti infection: treatment with splenic artery embolization. , 2011, Journal of vascular and interventional radiology : JVIR.
[51] R. Nadelman,et al. Babesiosis in Lower Hudson Valley, New York, USA , 2011, Emerging infectious diseases.
[52] B. Sands,et al. Babesiosis in a patient on infliximab for Crohn's disease. , 2010, Inflammatory bowel diseases.
[53] L. Weiss,et al. Zoonotic babesiosis: overview of the disease and novel aspects of pathogen identity. , 2010, Ticks and tick-borne diseases.
[54] Samit R. Joshi,et al. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[55] P. Krause,et al. EDITORIAL: The problem of transfusion‐transmitted babesiosis , 2009, Transfusion.
[56] R. Civen,et al. Babesiosis Acquired through Blood Transfusion, California, USA , 2009, Emerging infectious diseases.
[57] Ivo M Foppa,et al. Persistent and relapsing babesiosis in immunocompromised patients. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[58] J. Daily,et al. Shared features in the pathobiology of babesiosis and malaria. , 2007, Trends in parasitology.
[59] A. Kratz,et al. Case records of the Massachusetts General Hospital. Case 17-2007. A 25-year-old woman with relapsing fevers and recent onset of dyspnea. , 2007, The New England journal of medicine.
[60] T. Avšič-Županc,et al. Evaluation of an indirect fluorescence immunoassay for the detection of serum antibodies against Babesia divergens in humans , 2006, Parasitology.
[61] R. Quick,et al. Description of Babesia duncani n.sp. (Apicomplexa: Babesiidae) from humans and its differentiation from other piroplasms. , 2006, International journal for parasitology.
[62] R. Houghton,et al. Demonstrable parasitemia among Connecticut blood donors with antibodies to Babesia microti , 2005, Transfusion.
[63] A. Limaye,et al. Babesia divergens–like Infection, Washington State , 2004, Emerging infectious diseases.
[64] S. Telford,et al. Increasing health burden of human babesiosis in endemic sites. , 2003, The American journal of tropical medicine and hygiene.
[65] D. R. Allred. Babesiosis: persistence in the face of adversity. , 2003, Trends in parasitology.
[66] S. Telford,et al. Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[67] P. Greenberg,et al. Severe babesiosis in Long Island: review of 34 cases and their complications. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[68] S. Telford,et al. Atovaquone and azithromycin for the treatment of babesiosis. , 2000, The New England journal of medicine.
[69] G. Birkhead,et al. Human babesiosis in New York State: Review of 139 hospitalized cases and analysis of prognostic factors. , 1998, Archives of internal medicine.
[70] R. Pollack,et al. Persistent parasitemia after acute babesiosis. , 1998, The New England journal of medicine.
[71] S. Telford,et al. Diversity of Babesia infecting deer ticks (Ixodes dammini). , 1998, The American journal of tropical medicine and hygiene.
[72] B. Cunha,et al. Relative bradycardia and lymphopenia in patients with babesiosis. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[73] S. Ong,et al. Human babesiosis in Taiwan: asymptomatic infection with a Babesia microti-like organism in a Taiwanese woman , 1997, Journal of clinical microbiology.
[74] S. Telford,et al. Efficacy of immunoglobulin M serodiagnostic test for rapid diagnosis of acute babesiosis , 1996, Journal of clinical microbiology.
[75] R. Pollack,et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. , 1996, JAMA.
[76] M. Falagas,et al. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[77] B. Herwaldt,et al. A Fatal Case of Babesiosis in Missouri: Identification of Another Piroplasm That Infects Humans , 1996, Annals of Internal Medicine.
[78] S. Telford,et al. Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody. , 1994, The Journal of infectious diseases.
[79] H. Tanowitz,et al. Therapy of experimental babesiosis. , 1982, Annals of internal medicine.
[80] R. Hirsch,et al. Successful chemotherapy of transfusion babesiosis. , 1982, Annals of internal medicine.
[81] S. Cohen,et al. Treatment of babesiosis in asplenic patients. , 1981, JAMA.
[82] F. G. Wallace,et al. A newly revised classification of the protozoa. , 1980, The Journal of protozoology.
[83] P. Krause,et al. Coinfection by Ixodes Tick-Borne Pathogens: Ecological, Epidemiological, and Clinical Consequences. , 2016, Trends in parasitology.
[84] Peter J. Krause,et al. Human babesiosis. , 2012, The New England journal of medicine.
[85] J. Rich,et al. Red cell exchange transfusion for babesiosis in Rhode Island , 2009, Journal of clinical apheresis.
[86] Peter J. Krause,et al. Human babesiosis. , 2008, Infectious disease clinics of North America.
[87] A. Spielman,et al. CHAPTER 1 – Babesial Infections in Humans and Wildlife , 1993 .
[88] A. Spielman,et al. Ecology of Ixodes dammini-borne human babesiosis and Lyme disease. , 1985, Annual review of entomology.
[89] G. Healy,et al. Development and persistence of antibody in persons infected with Babesia microti. , 1981, The American journal of tropical medicine and hygiene.
[90] G. Healy,et al. Human babesiosis on Nantucket Island. Clinical features. , 1977, Annals of internal medicine.